首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   66992篇
  免费   5185篇
  国内免费   2774篇
耳鼻咽喉   511篇
儿科学   1318篇
妇产科学   1473篇
基础医学   7792篇
口腔科学   1025篇
临床医学   6983篇
内科学   13837篇
皮肤病学   889篇
神经病学   5372篇
特种医学   2537篇
外国民族医学   15篇
外科学   8145篇
综合类   5761篇
现状与发展   6篇
一般理论   2篇
预防医学   3843篇
眼科学   1227篇
药学   6377篇
  37篇
中国医学   2465篇
肿瘤学   5336篇
  2024年   147篇
  2023年   791篇
  2022年   2003篇
  2021年   2787篇
  2020年   1968篇
  2019年   1821篇
  2018年   1972篇
  2017年   1761篇
  2016年   1766篇
  2015年   2411篇
  2014年   3079篇
  2013年   3292篇
  2012年   4393篇
  2011年   4733篇
  2010年   2869篇
  2009年   2559篇
  2008年   3555篇
  2007年   3575篇
  2006年   3377篇
  2005年   3261篇
  2004年   2664篇
  2003年   2379篇
  2002年   2071篇
  2001年   1892篇
  2000年   1841篇
  1999年   1758篇
  1998年   758篇
  1997年   655篇
  1996年   600篇
  1995年   513篇
  1994年   456篇
  1993年   330篇
  1992年   802篇
  1991年   657篇
  1990年   632篇
  1989年   627篇
  1988年   525篇
  1987年   487篇
  1986年   453篇
  1985年   340篇
  1984年   268篇
  1983年   218篇
  1982年   123篇
  1979年   216篇
  1978年   128篇
  1977年   110篇
  1974年   122篇
  1973年   125篇
  1972年   122篇
  1971年   110篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
12.
13.
14.
15.

Introduction/Hypothesis

Recruitment of participants into phase 1 vaccine clinical trials can be challenging since these vaccines have not been used in humans and there is no perceived benefit to the participant. Occasionally, as was the case with a phase 1 clinical trial of an Ebola vaccine in Halifax, Canada, during the 2014–2016 West African Ebola virus outbreak, recruitment is less difficult. In this study, we explored the motivations of participants in two phase 1 vaccine trials that were concurrently enrolling at the same centre and compared the motivations of participants in a high-profile phase 1 Ebola vaccine trial to those in a less high-profile phase 1 adjuvanted seasonal influenza vaccine study.

Methods

An online survey which included participants’ prior experience with clinical trials, motivations to participate (including financial incentives), and demographic information was developed to examine the motivations of healthy participants in two phase 1 clinical vaccine trials conducted at the Canadian Center for Vaccinology in Halifax, Nova Scotia. Participants were invited via email to complete the online survey. Readability and clarity were assessed through pilot testing.

Results

A total of 49 (55.7%) of 88 participants of the two studies completed the survey (22 [55%] of 40 participants from the Ebola vaccine study and 27 [56.3%] of 48 from the adjuvanted influenza vaccine study). Motivations that were most frequently ranked among participants' top three in both trials were (1) wanting to contribute to the health of others, (2) wanting to participate in something important, (3) wanting to contribute to the advancement of science, and (4) wanting to receive an incentive such as money or a tablet.

Conclusions/Recommendations

Although media attention and financial compensation were more often cited by Ebola vaccine trial participants as a reason to participate, both altruistic and self-interested factors were important motivations for participants in their decision to participate in a phase 1 vaccine clinical trial.  相似文献   
16.
17.
目的  测评医学生的共情能力现状,探讨人格特质对其共情能力的影响,为培养医学生的共情能力提供对策。方法  以上海市3所高校临床医学专业学生为研究对象,采用班级整群抽样的方式进行问卷调研。采用杰斐逊共情量表-医学生版(JSPE-S)和大五人格量表(NEO-FFI)分别评估医学生的共情和人格特质。结果  共发放问卷2 020份,回收有效问卷1 958份,有效率为96.93%。医学生的共情能力总分均值为(103.24±14.35)。共情能力总分与大五人格中的“外向性”“开放性”“宜人性”“严谨性”维度呈显著正相关(r=0.154~0.406, P<0.01),与大五人格中的“神经质”维度呈显著负相关(r=-0.175, P<0.01)。分层回归结果表明:“共情重要性”和“大五人格”量表的5个维度进入回归方程。其中,人格因素占可解释方差变异量的16.2%(P<0.01)。结论  我国医学生的共情能力低于国外医学生,重视人格特质的塑造有助于提高其共情能力。  相似文献   
18.

Background

Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.

Objectives

To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.

Methods

Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.

Results

Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.

Conclusions

These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study.  相似文献   
19.
20.
PurposeTwitter is an increasingly popular social media platform within the health care community. The objective of this analysis is to characterize the profile of radiation oncology–related tweets and Twitter users over the past 6 years.Methods and MaterialsUsing the web-based social media analytics platform Symplur Signals, we filtered tweets containing at least 1 of the following hashtags or key words: #radonc, #radiationoncology, "rad onc," or "radiation oncology." We evaluated radiation oncology–related Twitter activity between October 2014 and March 2020 for tweet frequency, tweet content, and individuals or groups posting tweets. We identified the most influential Twitter users contributing to radiation oncology–related tweets.ResultsFrom 2014 to 2020, the quarterly volume of radiation oncology–related tweets increased from 5027 to 29,763. Physicians contributed the largest growth in tweet volume. Academic radiation oncologists comprise 60% of the most influential Twitter accounts responsible for radiation oncology–related content. The number of radiation-oncology resident physicians on Twitter increased from 25 to 328 over the past 6 years, and 20% of radiation-oncology residency programs have a Twitter account. Seventy-one percent of radiation oncology–related tweets generated direct communication via mentions, and 59% of tweets contain links to external sources, including scientific articles.ConclusionsThe number of physicians contributing radiation oncology–related Twitter content has increased significantly in recent years. Academic radiation oncologists are the primary influencers of radiation oncology–related Twitter activity. Twitter is used by radiation oncologists to both professionally network and discuss findings related to the field. There remains the opportunity for radiation oncologists to broaden their audience on Twitter to encompass a more diverse community, including patients.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号